The market, in seven rooms

Following TSMC's strong Q2 earnings with 36% revenue growth and 77% EPS increase, the author recommends buying TSMC, Nvidia, and Broadcom as attractive opportunities. TSMC's $100 billion Arizona investment and CEO projections of strong demand through 2029-2030 signal continued AI chip demand. Nvidia and Broadcom are trading below all-time highs despite strong growth forecasts, presenting buying opportunities in the AI semiconductor sector.

The cruise industry has completed its post-pandemic recovery with healthy occupancy rates and pricing. Among the three largest cruise operators, Royal Caribbean is recommended as the top buy due to its strongest financial results, industry-leading profitability, record bookings, and healthier balance sheet compared to Carnival and Norwegian Cruise Line, which both carry higher debt levels relative to their earnings.

TSMC reported strong Q2 results with 34% year-over-year revenue growth to $40.7 billion and gross margin expansion to 67.6%. The company raised full-year revenue guidance to over 40% growth and increased 2026 capex budget to $60-64 billion, signaling sustained AI chip demand. Trading at a forward P/E of ~20x, the stock is viewed as attractively valued given its monopolistic position in advanced chip manufacturing.

Microsoft stock has declined 27% from its all-time high due to Wall Street concerns over heavy AI infrastructure capital spending ($190B in 2026). However, the company's strong enterprise relationships, 16% projected annual earnings growth, and leadership in agentic AI through its Copilot platform position it to potentially double by 2030. With nearly 90% of Fortune 500 companies using Copilot Studio and a $627B backlog, Microsoft's long-term competitive advantages may offset near-term margin pressures.

ASML raised its 2026 sales outlook to 43-45 billion euros, driven by strong AI-related chip demand. The company plans 30% capacity expansions for its EUV lithography machines in 2027 and 2028. While the business fundamentals are strong with potential for 8-12% annual returns over five years, the stock's 121% run-up has created a valuation risk, trading at 40x 2026 earnings with limited room for error.

Elon Musk publicly reversed his previous dismissal of Anthropic, now calling it 'obviously currently the leader in AI.' This validation is significant for Amazon and Alphabet, which hold major stakes in Anthropic (Alphabet ~14%, Amazon mid-to-high teens) worth over $100 billion each. Both companies also benefit from massive long-term cloud service commitments from Anthropic. However, investors should note that recent AI-related gains are largely paper valuations rather than sustainable operating earnings, and the arrangement depends on continued AI boom momentum.

Coca-Cola stock has surged nearly 20% year-to-date, outperforming the S&P 500, driven by investor appreciation for its dividend reliability and strong Q1 results. However, the article suggests the stock's rise may be ending as it trades at an expensive 24x forward earnings for a low-growth company. With Q2 earnings due July 28 and management guiding for slower growth later in the year, the stock may have limited upside despite its quality as a dividend investment.

While both Nvidia and AMD have benefited from AI accelerator demand, their business strategies diverge significantly. Nvidia has concentrated 92% of revenue in data center AI chips, achieving 85% revenue growth and trading at 31x earnings. AMD maintains a more diversified portfolio across CPUs, GPUs, and embedded chips, with 56% from data center and 35% from client/gaming segments, posting 38% revenue growth but trading at a higher 161x P/E ratio. Nvidia's first-mover advantage and lower valuation make it the more attractive buy despite AMD's solid diversification strategy.

Intel's stock surged 278% in H1 2026 under CEO Lip-Bu Tan due to successful 18A process adoption and foundry business wins from Tesla and Apple. However, a 10% single-day drop in July suggests the stock price has outpaced fundamentals. With forward P/E ratios of 127-89 and modest 7% revenue growth, analysts recommend holding rather than buying, as the valuation appears years ahead of anticipated earnings growth.

Netflix stock has declined 24% year-to-date and 42% over the past 12 months following disappointing Q3 guidance, despite solid Q2 results. The article argues the stock presents a buying opportunity due to Netflix's potential expansion into sports streaming and its attractive valuation metrics compared to tech sector averages.

Chubb, the world's largest publicly traded property and casualty insurer, trades at a 12x P/E ratio compared to the S&P 500's 32x multiple, suggesting potential undervaluation. The company has delivered 226% total returns over the past decade and expects continued growth through middle-market expansion, AI upgrades, and higher fixed-income yields. With a 33-year dividend increase streak and a $7.5 billion buyback authorization, Chubb appears to be a stable, defensive investment opportunity.

Netflix delivered a 21% annualized return over the past decade, turning a $10,000 investment into $68,500. However, the company faces a growth deceleration with revenue growth slowing from 17.6% to a forecasted 11.7%, though Q2 results were solid with 13% YoY revenue growth and expanding operating margins. The stock trades at 21x forward earnings, down 47% from its 52-week high, with advertising and live programming emerging as key growth drivers.

Intuitive Surgical's stock fell this week despite beating Q2 earnings expectations with 19% revenue growth and 25% adjusted net income growth. The decline was triggered by management's decision not to raise full-year guidance, signaling slower growth ahead. Wall Street responded with multiple price target cuts as investors sold shares.

JPMorgan Chase and Goldman Sachs reported strong Q2 earnings driven by investment banking growth. CEO Jamie Dimon projects AI spending will reach over $1 trillion in 2027, up from $700 billion in 2026, signaling continued economic expansion fueled by AI infrastructure investment.

Nvidia remains the dominant AI chipmaker under CEO Jensen Huang's visionary leadership. The company has strategically positioned itself across the entire AI infrastructure stack through key acquisitions (Mellanox, Groq assets) and product development, including GPUs, CPUs, and LPUs. Trading at 16x fiscal 2028 earnings estimates with strong growth, Nvidia is well-positioned for future AI markets including inference and agentic AI workloads.

The Milton Hershey School Trust sold 30,000 shares of Hershey Company stock for approximately $5.2 million on July 13-14, 2026, at weighted-average prices ranging from $169.44 to $177.64 per share. The trust retains substantial ownership with ~1.3 million common shares and ~54.6 million Class B shares. The transaction is characterized as routine portfolio management and should not concern investors. Hershey faces headwinds from cocoa prices and GLP-1 medicines but trades at a reasonable 20x forward earnings with a 3.4% dividend yield.

A securities fraud class action lawsuit has been filed against Zoetis Inc. for allegedly making materially false statements about product adoption during the class period of January 14, 2025 through May 6, 2026. The lawsuit alleges the company misrepresented the performance of key products including Librela, Simparica Trio, Apoquel, and Cytopoint. Zoetis's stock fell 21.5% on May 7, 2026, following disappointing first quarter results showing significant decline in its Companion Animal business. Investors have until July 27, 2026, to file for lead plaintiff status.

NextEra Energy plans to invest $59 billion annually through 2032, with its acquisition of Dominion Energy positioning the combined company to capitalize on expected 60% growth in electricity demand by 2045. The capital spending is projected to support 9%+ annualized earnings growth and enable the company to maintain its decades-long dividend increase streak, making it attractive for dividend growth investors.

ASML, which holds a practical monopoly on extreme ultraviolet (EUV) lithography technology, is seeing surging demand for its equipment driven by booming AI chip and memory markets. The company reported Q2 revenue of €9.3 billion, beating guidance, and raised its 2026 revenue forecast to €43-45 billion. With plans to increase manufacturing capacity by 30% and potentially another 30% in 2028, ASML appears well-positioned for long-term growth despite trading at a premium 35.5x forward P/E ratio.

Tesla delivered a record 480,126 vehicles in Q2 2026, up 25% year-over-year, but investors will focus on automotive gross margin excluding regulatory credits when earnings are reported on July 22. The key metric has improved for four consecutive quarters, reaching 19.2% in Q1 2026. If margins hold near 19% on record volume without one-time benefits, it supports the bull case; if they decline to mid-teens, it suggests volume was achieved through discounts rather than genuine profitability gains.

CFRA analysts recommend selling SpaceX and buying Micron. SpaceX, despite dominating the space industry with reusable rocket technology and Starlink's 12 million subscribers, trades at an expensive 88x sales valuation with a sell target of $115 (12% downside). Micron benefits from severe memory chip supply shortages with DRAM and NAND prices up 90-110% annually, posting 345% revenue growth and 1,215% earnings surge, with a buy target of $1,500 (76% upside) and expected 115% annual sales growth through fiscal 2027.

Travelers Companies (TRV) surged 9.22% on Friday following a strong Q2 earnings report that significantly beat analyst expectations. Net income jumped 46% to $2.2 billion ($10.26 per share), crushing the consensus estimate of $5.34, driven by lower catastrophe losses, favorable reserve development, and higher investment income. However, revenue growth was modest at 1% year-over-year, and net written premiums declined slightly, suggesting the strong profitability may not be sustainable.

Five Star Bancorp announced a cash dividend of $0.25 per share payable on August 10, 2026. The company continues its expansion strategy with the opening of a new branch in Lodi, California in July 2026, bringing its total to ten branches. Five Star also made four key hires in Palo Alto to support San Francisco Bay Area expansion.

Law firm Kirby McInerney LLP is investigating potential securities fraud claims against Pentair plc following the company's July 14, 2026 announcement of significantly reduced financial guidance and immediate CFO departure. Pentair reported Q2 sales of ~$930M (17% decline vs. expected 1% growth) and adjusted EPS of ~$1.12 (vs. prior guidance of $1.47-$1.50), citing inventory realignment issues and worsening business conditions. The stock fell 15% to $64.33 on the news.

Major stock indices declined on July 17, 2026, as a semiconductor sell-off deepened amid geopolitical tensions and concerns about AI spending sustainability. The Nasdaq fell 1.40%, S&P 500 dropped 1.01%, and Dow Jones slipped 0.77%. Travelers Companies surged 9% on strong earnings, while chip stocks including Nvidia, AMD, and Intel tumbled. The PHLX Semiconductor Index has fallen over 13% in the past month despite being up 63% year-to-date.

Apple has committed $851 billion to share buybacks since 2012 under Tim Cook's leadership, reducing outstanding shares by over 40% and boosting diluted earnings per share by 373% over 13 years. Despite sitting out the AI boom, Apple's stock has risen 22% in 2026 and 1,250% over the past decade, demonstrating the effectiveness of its capital allocation strategy focused on returning cash to shareholders rather than major acquisitions.

Chino Commercial Bancorp reported Q2 2026 net earnings of $1.82 million, up 18% year-over-year, with EPS of $0.47. Year-to-date earnings reached $3.51 million, up 21%. The bank achieved record total assets of $519 million, deposits of $391.6 million, and loans of $242.1 million. The company announced a 20% stock dividend and highlighted strong loan quality with only two delinquent loans and robust merchant services growth of 37% in card processing volume.

nVent Electric plc will report second quarter 2026 financial results on July 31, 2026, with a conference call at 9:00 a.m. ET. The company has appointed Nitin Jain as Chief Strategy Officer and Joe Stark as Chief Revenue Officer to drive growth in electrification and accelerate the next phase of company expansion.

KeyBanc set a $725 price target on AMD, implying a 40% gain, but analyst Keithen Drury argues this is overly optimistic. AMD trades at a premium valuation despite lagging Nvidia in AI accelerators and lacking the profit margins to justify current prices. Even under highly optimistic scenarios, AMD would trade at 36x forward earnings, making Nvidia the better investment.

SpaceX stock fell below its IPO price on Friday, dropping 4% to $125.93 per share. Despite near-term headwinds including competition from China, delayed Starship tests, and AI sector selloffs, analysts project 152% annual earnings growth over five years, suggesting the stock may be approaching fair value.

The Nasdaq fell 2.5% for the week amid concerns about unsustainable AI infrastructure spending, with major tech stocks declining. The Dow remained relatively stable, buoyed by strong earnings from Travelers and UnitedHealth Group. Chip stocks faced particular pressure following Taiwan Semiconductor's increased capex forecast and IBM's profit warning, while Netflix dropped 8.5% despite meeting expectations.

Micron Technology has experienced a 30% pullback from its 52-week high despite strong quarterly results, presenting a buying opportunity for long-term investors. The company benefits from structural demand for memory chips driven by AI data centers, with supply shortages expected to persist beyond 2030. Analysts project 785% EPS growth in fiscal 2026, with potential for the stock to reach nearly $2,000 by 2030 if earnings growth continues and the company trades at a modest 10x earnings multiple.

Procter & Gamble raised its quarterly dividend by 3% in April, marking its 70th consecutive year of dividend increases and 136 years of continuous dividend payments since 1890. With a current yield of 2.9%, a payout ratio of 63%, and plans to distribute $10 billion in dividends in fiscal 2026, P&G demonstrates the durability of its consumer staples business. The stock trades at 21x earnings, offering a reasonable valuation for income-focused investors seeking dependable dividend growth.

Netflix's stock plummeted following disappointing Q2 earnings, with revenue growth slowing to 13.4% and weak forward guidance of 11.7% for Q3—its slowest growth in three years. The company is pursuing acquisitions and exploring free trial eligibility and ad-supported tiers as organic growth stalls, signaling desperation rather than strategic expansion. While profitability improved, investors are concerned about slowing subscriber growth and the company's ability to maintain momentum.

As AI data centers proliferate globally, electricity demand is surging, creating significant opportunities for utility stocks. Three electric utilities are particularly well-positioned to benefit: Constellation Energy (nuclear power focus with direct Meta deals), Entergy (supplying Meta's $50B Louisiana data center), and NextEra Energy (merging with Dominion to gain exposure to Virginia's 'data center alley'). All three stocks offer dividend growth potential alongside earnings expansion driven by AI infrastructure demand.

Sandisk has secured a long-term supply agreement with Meta Platforms for NAND flash memory chips to support Meta's AI data center expansion. With a $42 billion revenue pipeline from five multi-year agreements, expected memory chip shortages lasting 4-5 years, and variable pricing riders that capture upside from price increases, analysts project Sandisk's stock could reach $4,657 (2.6x upside) if earnings reach $232.88 per share within two years.

CSW Industrials declared a regular quarterly cash dividend of $0.30 per share payable August 14, 2026. The company reported robust fiscal 2026 fourth quarter results with record quarterly and full year performance, with the Contractor Solutions segment returning to positive organic growth.

Cloudastructure reported Q1 2026 revenue of $1.315 million, up 78% year-over-year, with recurring revenue reaching an annualized run rate of $2.6 million. The company expanded its AI-driven security platform across multifamily, transportation, and logistics sectors, now serving 8 of the top 10 NMHC-ranked multifamily property managers. Despite strong revenue growth, the company posted a net loss of $2.8 million as it continues investing in platform scaling and operational expansion.

Tesla's Q2 earnings on July 22 are expected to show strong EV delivery growth (~480k units) and automotive revenue around $20.1-20.7B, up 22% YoY. However, the article suggests investors shouldn't rush to buy before earnings as major announcements on Optimus robots or robotaxi/v15 software are unlikely, with no game-changing catalysts expected. Long-term investors can wait to buy as the stock lacks near-term catalysts.

Advanced Flower Capital Inc. (Nasdaq: AFCG) announced it will release its Q2 2026 financial results on August 13, 2026, with a management webcast at 10:00 am ET. The company also committed $7 million to a $25 million senior secured credit facility and announced a dividend for Q2 2026.

Abacus Global Management (NYSE: ABX) announced it will release its second quarter 2026 financial results on August 6, 2026, followed by a conference call at 5:00 pm ET. The company will provide a live webcast on its investor relations website.

Enovis Corporation (NYSE: ENOV) announced it will host an investor conference call on August 6th, 2026 at 8:30 a.m. Eastern Time to discuss its second quarter 2026 financial results. The company will issue an earnings press release that morning, with the live webcast and presentation accessible from its website.

AMD reports Q2 earnings on Aug. 4 with high expectations for 47% revenue growth. The stock has surged 130% in 2026 and trades at a 75x forward P/E ratio, making it vulnerable to disappointment. Nvidia, trading at only 24x forward earnings despite faster expected growth (~100%), could benefit if AMD confirms strong AI demand. Analysts suggest Nvidia offers better value than AMD at current valuations.

Ares Capital (ARCC) offers a 10.2% dividend yield, significantly higher than the S&P 500's 1%. A $2,000 investment would purchase approximately 105 shares at $19 per share, generating $100.80 in dividend income by year-end if the current $0.48 quarterly dividend is maintained. The BDC has maintained a stable-to-growing dividend for over 16 years, with sufficient earnings cushion to support the current payout level through 2030.

ON Semiconductor announced a $7 billion all-stock acquisition of AI edge solutions company Synaptics, transforming itself from a power and sensing chip company into one offering connected compute technology for physical AI applications. While the market initially reacted negatively, management expects the deal to add to earnings within 18 months, generate $200 million in synergies, and expand the company's total addressable market by $30 billion to $243 billion by 2030. The analyst views the stock dip as a buying opportunity, positioning the move as a bold but strategic entry into the long-term AI inference market.

Aehr Test Systems stock surged 20.9% following strong Q4 earnings that confirmed the company's successful transition from the EV market to the higher-growth AI processor market. The company reported record bookings of $60.7 million and a $100 million backlog, with management projecting fiscal 2027 revenue of $130-150 million compared to $50 million in 2026. AI-related products now represent approximately 71% of annual revenue, up from less than 5% two years ago.

Click Holdings Limited announced it has delivered over 6 million cumulative senior care service hours and unveiled a global ESG framework to support expansion into Mainland China and international markets. The company reported 73% year-over-year Q3 revenue growth with 110% growth in its senior nursing division, and targets HK$500 million in annual revenue within three years by leveraging its AI-powered HR and senior care solutions.

CrossAmerica Partners LP announced it will release its second quarter 2026 earnings results on August 5, 2026, followed by a conference call on August 6 at 9:00 a.m. Eastern Time. The company is a leading wholesale distributor of motor fuels operating across 34 states with approximately 1,500 distribution locations.

PayPal is reportedly up for sale with Stripe and Advent International bidding $60.50 per share. The acquisition offer has caused PayPal stock to surge 17%, though some investors like Michael Burry argue the bid is too low. The real prize in the deal is considered to be Venmo, PayPal's popular payment platform.

SpaceX stock (SPCX) has experienced a significant drop, falling 5.43% to $123.99 as of July 17, 2026. The article discusses whether this decline presents a buying opportunity for investors, with the stock dropping below its IPO price following a delayed Starship launch.

While Eli Lilly's GLP-1 weight-loss drugs (Mounjaro and Zepbound) account for nearly two-thirds of revenues with strong growth, the company is strategically using profits from these drugs to build a diversified pipeline in immunology, oncology, and neuroscience through acquisitions like AtaiBeckley and Ventyx Biosciences. Non-weight-loss drugs are already showing 160% revenue growth, positioning Eli Lilly for long-term success beyond the limited patent life of GLP-1 drugs.

MKDWELL Tech Inc., an automotive electronics manufacturer, announced it will acquire Landvision Inc., a developer of AI-enabled smart-home and IoT products, for $240 million through the issuance of 30 million new shares at $8.00 per share. The acquisition aims to diversify MKDWELL's business into the high-growth consumer smart-home sector while leveraging complementary strengths in embedded electronics and manufacturing. Completion is expected in August 2026.

A class action lawsuit has been filed against GPGI, Inc. in the U.S. District Court for the Southern District of New York on behalf of investors who purchased GPGI Class A common stock between November 3, 2025 and May 6, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding the overstatement of Husky's value, failure to disclose that Husky was not on track to meet revenue and EBITDA targets, and that the acquisition was primarily motivated by generating fees rather than creating shareholder value.

newcleo received a satisfactory safety opinion from French nuclear authority ASNR for its planned MOX fuel facility. The company has outgrown the France 2030 program scope due to significant capital raises and international expansion, including a planned NASDAQ listing via SPAC merger valuing it at $2.4 billion. France will continue supporting newcleo through licensing and regulatory assistance rather than direct funding.

SpaceX stock fell below its IPO price after the company scrubbed a Starship test flight due to two Raptor engines failing to ignite on the Super Heavy booster. The engines will be replaced and the launch rescheduled for early next week. The analyst argues this delay is not a significant concern for long-term investors.

S&P Global completed a spinoff of its Mobility division (now Mobility Global) on July 1, 2026, creating a leaner, more focused company. The mobility business was S&P Global's smallest and lowest-margin operation (22% margins vs. 40% company average), so the separation should improve overall profitability and allow management to focus on core strengths in ratings and market intelligence. The company's 53-year dividend growth streak remains intact.

SpaceX's stock fell below its $135 IPO price following a Starship launch delay, but the article argues the delay itself is unlikely to materially impact the company's long-term investment thesis. The stock decline is attributed more to thin trading float (only 4% of shares trade publicly), AI sector sell-offs, and pending lock-up expirations rather than the business fundamentals. Near-term revenue drivers like Starlink and AI compute deals remain unaffected by the delay.

Robinhood Markets CFO Shiv Verma sold 3,982 shares worth approximately $457,000 on July 15, 2026, under a pre-arranged Rule 10b5-1 trading plan. The sale reduced his direct stake by 7%, leaving him with 55,945 shares valued at $6.5 million. The analyst notes this modest disposal should not concern investors, as the company's operations remain strong with 39% growth in platform assets, 15% revenue increase, and expanding product offerings.

The iShares Semiconductor ETF (SOXX) is positioned to outperform the VanEck Semiconductor ETF (SMH) due to superior portfolio construction. While both are market-cap-weighted semiconductor ETFs with similar holdings, SOXX applies stricter weighting caps (8% for top 5 holdings, 4% for others) compared to SMH's 20% limit. This makes SMH dangerously concentrated with a 30% combined allocation to Nvidia and TSMC, creating significant concentration risk. SOXX's more diversified approach is expected to provide better risk-adjusted returns over the next 6-12 months.

Wall Street analysts are bullish on Viking Therapeutics (VKTX), with a consensus price target of $91 representing a potential 150% return. The optimism centers on VK2735, a dual-formulation weight-loss drug showing promising phase 2 efficacy data. However, key phase 3 results won't arrive until late 2027-2028, and some phase 2 oral trial tolerability concerns exist. Cautious investors may want to wait for upcoming maintenance trial results before investing.

Despite Sandisk's 580% rally in 2026, analyst recommends three chip stocks as smart buys: Sandisk, Micron Technology, and Nvidia. The memory chip shortage is expected to persist beyond 2027, benefiting memory producers. Nvidia trades at an unusually low 23.7x forward P/E ratio despite 85% revenue growth and expected 42% growth in 2027, presenting a potential undervaluation opportunity.

StubHub stock fell 13% this week after Washington, D.C. passed the RESALE Act, capping secondary ticket resale markups at 10%. Analyst Jason Bazinet estimates that if similar caps averaging 15% are implemented across multiple jurisdictions currently considering such measures, StubHub's revenue could decline by 30% and EBITDA could drop by $95 million if 20% of sales are affected.

Pentair stock plummeted 18.5% to a 52-week low after the company slashed its full-year sales guidance from +2-4% growth to -4-7% decline, citing pool inventory destocking and worsening business conditions. The decline was compounded by the abrupt departure of CFO Nicholas Brazis after just four months, analyst downgrades, and securities fraud investigations into the company's disclosure practices.

Meta is planning massive AI data center spending of $125-145 billion in 2026 alone, but CEO Mark Zuckerberg has not provided concrete details on expected returns on investment. While the company's advertising business is performing well, analysts question whether these unprecedented capital expenditures will generate adequate returns. Meta's recent announcement to lease excess compute capacity suggests potential overbuilding.

The article compares two aerospace technology stocks: Archer Aviation, developing electric vertical takeoff and landing aircraft for urban air mobility, and AST SpaceMobile, building a space-based cellular broadband network. While Archer faces regulatory certification hurdles and slower revenue generation, AST SpaceMobile shows stronger revenue growth trajectory and competitive moats through partnerships with major telecom operators. The analyst recommends AST SpaceMobile as the better buy for 2026 due to its faster path to profitability and established partnerships, despite higher capital expenditures.

WD-40 earns a Superscore of 79 out of 100 for its strong operational efficiency, robust margins (56.6%), and disciplined focus on high-margin maintenance products. However, the stock trades at a stretched valuation (P/E of 37.7) with limited growth prospects, structural headwinds from commoditization and the EV transition, and is expected to underperform the S&P 500 over the next five years.

Publicis Groupe announced strong first half 2026 results with Q2 net organic growth accelerating to +4.8%, up from Q1's +4.5%. The company has upgraded its guidance for the second half of 2026 based on continued momentum across key regions.

Berkshire Hathaway Energy is positioning itself to capitalize on growing electricity demand from AI data centers. CEO Greg Abel noted that the subsidiary is already supplying 8% of its Iowa electricity production to AI data centers, with potential for 50%+ growth over five years. However, while the opportunity is real, AI currently represents only about 4% of U.S. electricity consumption, limiting its significance as a core growth driver for the conglomerate.

Grab Holdings Limited CFO Peter Oey sold 50,000 Class A Ordinary Shares on July 15 for approximately $191,500, leaving him with 6.9 million shares worth $26.4 million. The sale was executed under a 10b5-1 trading plan, which pre-establishes transaction timing to avoid any appearance of trading on material non-public information. Similar share sales by CEO Anthony Tan and CPO Philipp Kandal in July were also conducted under 10b5-1 plans. Grab's stock has underperformed the broader market, declining 33.2% over the past year.

The Vanguard Small-Cap Growth ETF (VBK) is outperforming the S&P 500 with small-cap stocks up 21.4% year-to-date versus the S&P 500's 9.5% gains. The ETF holds 544 stocks with a low 0.05% expense ratio, making it an attractive option for risk-tolerant long-term investors seeking small-cap growth exposure without excessive volatility.

Warren Buffett announced plans to donate his entire $140 billion fortune to charity by December 31, 2034, accelerating his philanthropic efforts. This week, he converted 8,000 Berkshire Hathaway Class A shares into 12 million Class B shares to donate to four foundations tied to his family, with approximately $17 billion per year in grants required to meet the 2034 deadline. The donations will be distributed gradually over eight years to minimize stock price volatility.

GE Aerospace announced that its GEnx-1B engine has reached 50 million flight hours in just over 14 years, the fastest rate for any GE commercial widebody engine. The engine powers Boeing 787 Dreamliners and maintains a 99.98% dispatch reliability rate. GE Aerospace is investing $1 billion in U.S. manufacturing and supply chain enhancements to meet growing demand.

Reddit CEO Steve Huffman sold 18,000 shares worth $3.6 million on July 15, 2026, through a pre-planned Rule 10b5-1 trading plan adopted over a year prior. Despite the sale, Huffman maintains substantial holdings of over 450,000 indirect shares and 1.1 million derivative securities, indicating continued alignment with shareholders. The transaction should not concern investors as it was non-discretionary and follows standard executive practice.

Warren Buffett confirmed he initiated Berkshire Hathaway's $4 billion investment in Alphabet, with CEO Greg Abel adding another $23 billion. Buffett, who historically avoided tech stocks, changed his mind because Alphabet has become a massive cash-generating machine with the ability to deploy hundreds of billions into AI data centers. Alphabet's full-stack cloud approach, custom TPU chips, and $462 billion in contracted revenue make it well-positioned to generate strong returns on capital.

The author recommends Brookfield Renewable and Realty Income as core passive income holdings for the next decade. Both companies offer high dividend yields (4.5%+ and 4.9% respectively), strong dividend growth track records, stable financial profiles, and significant growth potential. Brookfield Renewable benefits from renewable energy development projects and contracted cash flows, while Realty Income leverages private capital partnerships and a large addressable market in net-lease real estate.

Amazon's $200 billion AI investment is backed by strong fundamentals, including its Trainium chip business running at a $20 billion annual revenue pace with $225 billion in pre-committed customer contracts. The custom chip operation is growing at triple-digit percentages and offers better performance-per-dollar than competitors, allowing Amazon to build a more controlled and cost-efficient AI supply chain.

ServiceTitan's CFO Sherry David sold 2,276 shares for approximately $181,000 on July 15, 2026, under a pre-scheduled Rule 10b5-1 trading plan established in January 2026. Despite the sale, David retains 395,756 shares worth $31.01 million. The transaction is viewed as routine portfolio management rather than a bearish signal, as the company continues to grow sales by 25% quarterly while improving margins despite AI-related market concerns.

Warren Buffett holds positions in both Apple and Alphabet. While Apple has an excellent business model with its closed-loop ecosystem and high-margin services, its valuation is stretched at a forward P/E of 35x. Alphabet, trading at a forward P/E below 25x, offers better value with strong AI capabilities, custom TPU chips, and significant growth opportunities, making it the better buy currently.

The article highlights MercadoLibre and Dutch Bros as two non-AI growth stocks with potential to double by 2030. MercadoLibre, a Latin American e-commerce and fintech leader, is growing at 49% year-over-year with plans to launch a digital bank in Mexico. Dutch Bros, a coffee chain, plans to nearly double its store count from 1,177 to 2,029 shops by 2029 with 31% year-over-year revenue growth.

Despite Tesla's stock price dropping below $400, the author recommends Cava Group as a better investment choice. Tesla faces concerns over shrinking profit margins, declining North American sales, and a valuation heavily dependent on unproven autonomous driving technology. Cava, a fast-growing Mediterranean restaurant chain, offers more reliable growth through strong customer traffic, profitable expansion, and a clear path to 1,000 locations by 2032.

Under new CEO Greg Abel, Berkshire Hathaway has significantly concentrated its $348 billion stock portfolio in Apple (20.6%) and Alphabet (8.8%), reflecting a strategic shift toward AI-driven tech companies. Abel tripled Berkshire's Alphabet position, including a $10 billion private placement to fund the company's $80 billion AI infrastructure expansion. While this concentration signals confidence in these companies' AI prospects and their durable competitive moats, it also increases portfolio risk if either company stumbles or AI investments fail to deliver expected returns.

Nvidia, currently valued at $5 trillion, could potentially double to $10 trillion by 2030 based on accelerating revenue growth (85-96% YoY) and dominant 80-90% market share in AI chips. However, the stock trades at a premium 20x price-to-sales ratio that would likely compress as growth inevitably slows, making the $10 trillion valuation dependent on maintaining 40-50% CAGR and a lower valuation multiple.

CrowdStrike and Snowflake are compared as AI-driven enterprise software leaders. CrowdStrike offers cloud-native cybersecurity with a recurring subscription model, reporting ~21.7% revenue growth and near-profitability. Snowflake provides an AI Data Cloud platform with a consumption-based model, showing ~29.2% revenue growth but deeper losses and higher debt. The article recommends CrowdStrike for 2026 due to its more stable recurring revenue model and profitability, despite both trading at premium valuations.

As Meta and other tech giants rapidly expand AI data center capacity, industrial suppliers Caterpillar and Eaton are experiencing significant growth. Caterpillar's backlog reached a record $63 billion (up 79% year-over-year) driven by demand for earth-moving equipment and power generators, while Eaton's Americas division backlog grew over 40% with order growth at 60%, fueled by AI infrastructure demand. Both companies are well-positioned to benefit from the ongoing data center construction boom, though their valuations are elevated at 45x and 38x P/E ratios respectively.

The article compares two healthcare ETFs: IHE (U.S. Pharmaceuticals) and IXJ (Global Healthcare). IHE offers concentrated exposure to 56 U.S. pharmaceutical companies with higher recent returns (50.30% 1-yr), but carries significant concentration risk with its top two holdings (J&J and Eli Lilly) comprising 43% of the portfolio. IXJ provides broader diversification across 110 international healthcare companies including medical devices and services, with lower concentration risk but more modest recent returns (18.20% 1-yr). The article suggests IXJ is better for diversification-focused investors, while IHE's outperformance is largely driven by GLP-1 weight-loss drug success.

SpaceX could deliver a 10x return if annual revenue reaches $3.6 trillion by 2040, aligning with Morgan Stanley's $3.4 trillion projection. Currently trading at $1.8 trillion market cap with $18.7 billion in 2025 revenue, the company would need a 5x price-to-sales ratio to reach an $18 trillion valuation. However, this scenario depends on successful execution of Starlink, Starship, and AI segments, with significant downside risk if any underperforms.

Meta shares surged 21% in July, adding $270 billion to its market cap, driven by the launch of its new cloud computing division under the Meta Compute initiative. The company plans to monetize excess AI infrastructure by selling unused compute resources to outside customers, addressing concerns about aggressive AI spending ($125-145 billion annually). Investors are optimistic about this strategic pivot to generate returns on massive capex investments, though the company's ability to deliver on AI ROI expectations remains critical.

Nvidia CEO Jensen Huang highlighted at CES 2026 that memory is becoming the critical bottleneck in AI development as large language models require increasing storage capacity. Memory and storage chip manufacturers Micron Technology and Sandisk have significantly outperformed Nvidia's stock since then, with both companies reporting surging revenues driven by AI infrastructure demand. Both companies are securing long-term customer contracts worth billions to stabilize their typically cyclical business.

4D Molecular Therapeutics (4DMT) announced positive 2-year results from its PRISM Phase 2b clinical trial of 4D-150, an intravitreal gene therapy for wet age-related macular degeneration (AMD). The single-dose treatment demonstrated consistent maintenance of visual acuity and anatomic control with 78-87% reduction in treatment burden compared to standard aflibercept injections. The therapy was well-tolerated with no new safety concerns or intraocular inflammation cases beyond the first 6 months.

Two Vanguard ETFs are outperforming the S&P 500 this year: the Information Technology ETF (VGT), up 21% driven by semiconductor companies benefiting from AI demand, and the Energy ETF (VDE), benefiting from Middle East conflicts and elevated energy prices. Both ETFs are concentrated in top holdings but positioned to finish ahead of the S&P 500.

C3.ai CEO Thomas Siebel sold 462,565 shares worth $4.2 million on July 14-15, 2026, exercising options at $3.90 and selling at $9.18 per share. The sale was part of a pre-scheduled Rule 10b5-1 trading plan adopted in September 2024 and does not indicate insider concern, as Siebel retains ~2.9 million shares and options. The stock has declined 66% over the past year, though Siebel's return as CEO following health-related absence may help the company rebound from a significant revenue drop.

Breast cancer patient Heidi Panych is participating in the 2026 Enbridge Tour Alberta for Cancer to share her story. The event attracted a record 2,300 cyclists and raised $12.5 million for cancer research and patient support programs in Alberta. Team Enbridge has collectively raised over $10 million since the company became title sponsor in 2010.

Vanguard S&P 500 Growth ETF (VOOG) is recommended over Vanguard Mega Cap Growth ETF (MGK) for long-term investors. While MGK offers a slightly lower expense ratio of 0.05% versus VOOG's 0.07%, VOOG's broader diversification across 148 holdings versus MGK's 56 holdings has delivered superior returns across most time periods, with VOOG returning 22.80% over one year compared to MGK's 18.80%.

The Vanguard S&P 500 ETF offers a simple, low-cost way to build wealth through consistent long-term investing in 500 large U.S. companies. With a 0.03% expense ratio and historical 15% average annual returns, investing $500 monthly could yield $1.36 million over 30 years. However, investors should be aware of market volatility, tech sector concentration, and the need for patience and a diversified portfolio strategy.

Meridian Holdings Inc. (NASDAQ: MRDN) announced that its subsidiary Meridianbet has been named the Official Sponsor of UFC Fight Night Serbia, scheduled for August 1, 2026 at Belgrade Arena. This marks the first UFC event ever held in Serbia, with Meridianbet serving as the exclusive sports-betting category sponsor. The sponsorship includes Octagon branding, marketing placements, and digital campaigns across UFC's global platforms.

SK Hynix, now trading on U.S. exchanges via ADR, is compared to Micron as a memory chip investment. SK Hynix leads the HBM market with 56% share and has a strategic partnership with Nvidia, while Micron has a longer track record but entered HBM later. Both companies are benefiting from strong AI infrastructure demand, though the volatile memory chip market poses risks. The article recommends SK Hynix for new investments despite Micron's lower valuation.

Pfizer's attractive 7% dividend yield masks significant risks as the company faces a patent cliff with major drugs losing protection in 2027-2028. With a dividend payout ratio over 130% and limited new drug candidates in the pipeline, investors are concerned about the sustainability of the dividend. However, the company has cash reserves and debt options to maintain payments, and management has prioritized dividend preservation.

Deanna Goodwin, a Board of Directors member at Oceaneering International, sold 7,000 shares (~$285,000) on July 1, 2026, at $40.69 per share, reducing her direct holdings by 16.32%. The sale occurred near recent highs as the stock was up 80.84% over one year. Despite the sale, Goodwin retained nearly 36,000 shares, suggesting continued confidence in the company's long-term prospects amid strong business developments including $1 billion in customer orders.

The Schwab U.S. Dividend Equity ETF (SCHD) has returned approximately 20% in 2026, outperforming both the S&P 500 and Nasdaq-100. The $95 billion fund focuses on companies with at least 10 consecutive years of dividend payments and screens for quality fundamentals. Its concentration in healthcare and consumer staples has benefited from a market rotation away from expensive AI and software stocks, though the fund's long-term job is delivering growing income from durable businesses rather than outrunning growth indexes.

SpaceX's Starship Flight 13 test launch was scrubbed when four Raptor engines failed to ignite at liftoff. The company faces mounting pressure from a 2028 NASA deadline for lunar missions and competition from Blue Origin. SpaceX stock has declined 38% from its all-time high, with investors bracing for continued volatility as the company pursues further test flights.

As AI workloads scale, high-bandwidth memory (HBM4) has become a critical bottleneck. Nvidia CEO Jensen Huang confirmed Nvidia will be the primary customer for HBM4 solutions to power its next-generation Vera Rubin architecture. SK Hynix has emerged as Nvidia's preferred partner, reportedly securing 50-70% of anticipated HBM4 orders through a multiyear co-development partnership announced in June, positioning it as a major beneficiary of the memory supercycle.

Starbucks has reversed its fortunes in 2026 through CEO Brian Niccol's 'Back to Starbucks' turnaround plan, featuring improved staffing, faster service, and renewed focus on in-store experience, resulting in positive comparable sales and recovered morning traffic. Dutch Bros' stock has pulled back despite strong 30%+ revenue growth and aggressive expansion plans, representing a valuation reset rather than business deterioration. For the second half of 2026, Starbucks appears the steadier near-term investment with dividend income and international growth potential, while Dutch Bros offers higher long-term upside for patient investors willing to accept volatility.

The article advocates for passive index investing through the Vanguard Total Stock Market ETF (VTI) rather than individual stock picking. VTI provides broad exposure to 3,500+ U.S. stocks with a low 0.03% expense ratio, allowing investors to participate in overall market growth without the difficulty and risk of selecting individual winners.

Warren Buffett's approach to stock market crashes centers on three key principles: recognizing that markets always recover to new highs, maintaining patience rather than panic-selling, and aggressively buying quality stocks at discounts when opportunities arise. Buffett's success stems from confidence in eventual market recovery and a long-term investment horizon, contrasting with most investors who move to cash during downturns and gradually re-enter after recoveries are obvious.

SpaceX could potentially reach a $5 trillion market cap if its Starmind initiative succeeds in processing AI workloads in space using a constellation of up to 1 million satellites. The company's space-based AI processing offers advantages like free solar power and lower cooling costs compared to terrestrial data centers. However, significant technological hurdles remain and investors may need to wait years for this vision to materialize.

SpaceX stock has declined 45% from its peak of $225.64 to $125, despite strong revenue growth projections and expansion into AI infrastructure. While Wall Street forecasts revenue could double to $39.2B in 2026 and reach $72.7B in 2027, the company trades at a P/S ratio of 88—14 times higher than the Nasdaq-100. Even accounting for future growth, SpaceX remains significantly overvalued and unprofitable, suggesting further downside risk.

Nvidia has emerged as a dominant force in the AI revolution with record revenues and profits, yet trades at a surprisingly low valuation compared to peers. With a forward P/E ratio of 23—between typical growth (29) and value (17) stocks—Nvidia appeals to both growth and value investors. The company's strong competitive position, established track record, and early-stage AI market opportunity make it an attractive long-term holding, though cautious investors should note risks from high AI spending levels and sector volatility.

Warren Buffett announced plans to dispose of all his Berkshire Hathaway shares within approximately eight years, accelerating his previous pledge to gradually give away his stock to philanthropic foundations. His remaining shares will be donated to four foundations, including three run by his children and one dedicated to his late wife. Buffett also halted his annual donations to the Gates Foundation due to concerns about Microsoft founder Bill Gates' interactions with disgraced financier Jeffrey Epstein.

Under new CEO Greg Abel, Berkshire Hathaway has increased its stakes in three Japanese trading houses—Mitsubishi, Sumitomo, and Marubeni—during Q2 2026. Berkshire's combined five trading house positions, worth $35.4 billion (up from $23.5 billion a year prior), generate $862 million in annual dividends and are funded with cheap yen-denominated debt at 1.2% interest, creating an attractive 5.6% yield on original cost.

The article discusses three undervalued dividend stocks suitable for long-term buy-and-hold investing strategies. It emphasizes that investing in dividend stocks is an excellent way to generate passive income and requires a different mindset compared to short-term trading.

WeRide has been recognized as one of China's top 10 AI case studies for its autonomous driving deployment in the UAE, the only autonomous driving company on the list. The company operates fully driverless Robotaxi services across Abu Dhabi, Dubai, and Ras Al Khaimah through Uber, and has expanded to additional markets including Riyadh, Singapore, Madrid, and Zurich, with operations in over 40 cities across 12 countries.

AST SpaceMobile is preparing to launch commercial satellite-based broadband services in early 2027, differentiating itself from Starlink through partnerships with major telecom providers like AT&T and Verizon. The company generated $15M in Q1 2026 revenue and projects $1B annual revenue post-launch, but faces execution risks. The stock has declined nearly 60% from recent highs, making it suitable only for aggressive investors willing to wait for proof of commercial viability.

A class action lawsuit has been filed against Peabody Energy Corporation (NYSE: BTU) on behalf of investors who purchased stock between October 14, 2024 and May 4, 2026. Shareholders allege the company misled investors about production rates at its Centurion mine, providing overly optimistic guidance that failed to materialize. The stock declined 9.7% on March 30, 2026 following a guidance cut, and another 5.7% on May 5, 2026 when the company disclosed failure to meet the mine's ramp-up deadline.

Etsy and Wayfair represent different e-commerce strategies in the discretionary spending market. Etsy maintains profitability with a 5.7% net margin and asset-light model, while Wayfair generates higher revenue ($12.5B vs $2.9B) but remains unprofitable with a -2.5% net margin. The article recommends Etsy for conservative investors seeking steady cash flow and Wayfair for aggressive investors betting on housing market recovery.

A class action lawsuit has been filed against Citadel Securities LLC and Virtu Americas LLC for allegedly engaging in 'spoofing' - a manipulative trading practice involving submitting and cancelling orders without intent to execute them - to artificially influence the price of Genius Group Limited (GNS) securities between April 2022 and May 2025. The defendants allegedly profited by misleading market participants about supply, demand, and volatility while increasing transaction costs for investors. The lead plaintiff deadline is August 28, 2026.

IBM shares plummeted 25% on July 14, 2026, erasing $68 billion in market value after CEO Arvind Krishna revealed severe underperformance in Q2 2026 results, particularly in the IBM Z mainframe business. The company had previously assured investors of 5%+ revenue growth but delivered only 1% total revenue growth with a 7% decline in Infrastructure revenue. Hagens Berman is investigating potential securities law violations regarding whether IBM management knew about deal closures risks earlier.

The article compares VanEck Gold Miners ETF (GDX) and iShares Silver Trust (SLV), two popular precious metals investment vehicles with different mechanics. While SLV provides direct exposure to physical silver bullion, GDX offers equity-based exposure to gold mining companies. Over five years, GDX delivered superior returns ($2,339 vs $2,196 on a $1,000 investment) with lower volatility. The article recommends GDX as the better buy, citing dividend income, favorable tax treatment compared to collectibles, and expectations for continued gold miner outperformance in 2026.

ServiceNow and UiPath are both positioned to capitalize on the growing agentic AI market, which is forecasted to grow at 46.2% CAGR through 2030. ServiceNow has faster revenue growth (22% YoY) and higher-paying customers, while UiPath recently achieved profitability and has better margin expansion potential. Both trade at similar P/E ratios, but UiPath offers better value for investors focused on margin improvement.

Iovance Biotherapeutics announced the grant of inducement stock options covering 139,930 shares to seventeen new non-executive employees on July 16, 2026, with an exercise price of $4.66 per share and a three-year vesting schedule. The grants were made under the company's Amended and Restated 2021 Inducement Plan in compliance with Nasdaq Listing Rule 5635(c)(4).

Law firm Bragar Eagel & Squire is investigating Pentair plc for potential securities law violations following the company's July 15, 2026 announcement of significantly lowered 2026 outlook, $170 million inventory destocking impact on Pool segment sales, and immediate CFO departure. Pentair's stock fell 15% ($11.35) to $64.33 per share on the news.

Dell Technologies and NVIDIA represent different plays on the AI boom. Dell has surged over 200% in 2026 with strong server sales driven by AI adoption, while NVIDIA remains the dominant chip leader with superior financials and a 55.6% net margin. Though Dell appears cheaper on valuation metrics, NVIDIA is recommended as the better long-term investment due to its market leadership, CUDA software dominance, and stronger balance sheet.

The article compares two precious metals ETFs: SPDR Gold Shares (GLD) and ABRDN Physical Silver Shares ETF (SIVR). While GLD offers lower volatility with a 0.40% expense ratio, SIVR is more cost-effective at 0.30% and has outperformed gold over the past 1, 3, 5, and 10 years. The author recommends SIVR as the better buy for 2026, citing silver's higher industrial demand from renewable energy applications and superior long-term performance.

DBV Technologies has filed a new S-3ASR registration statement with the SEC to renew its at-the-market (ATM) offering program for up to $150 million in American Depositary Shares (ADSs). The company plans to use proceeds primarily for manufacturing capacity expansion, pediatric BLA submissions for peanut allergy treatment, and product development. The program was established with Citizens JMP Securities as the placement agent.

Glencore has amended and restated its convertible facilities agreement with Tantalex Lithium Resources Corporation, maintaining US$5 million in aggregate convertible term loan facilities. The agreement includes a 20% ownership cap on conversion, a 1% gross revenue royalty on tin, lithium, and tantalum production, and expanded offtake agreements covering tin and tantalum from the TiTan project in the Democratic Republic of the Congo.

A Race Against Blindness, an Arizona-based nonprofit funding childhood blindness research, launched a two-week fundraiser (July 13-26, 2026) featuring a 2025 Volkswagen ID. Buzz 1st Edition 4MOTION and $20,000 in cash as the grand prize. The organization has granted over $6.1 million toward gene therapy research since its 2023 launch and aims to introduce supporters to electric vehicle benefits while advancing treatments for inherited retinal diseases.

The article compares SpaceX and Caterpillar as investment options in 2026. SpaceX shows impressive 33.2% revenue growth but operates at a $4.9 billion net loss with negative $14 billion free cash flow, trading at a 197.7x forward P/E ratio. Caterpillar generates $10.3 billion in annual free cash flow with 13.1% net margins and trades at 34.7x forward P/E. The author recommends Caterpillar as the safer choice due to profitability, dividend payments, and exposure to AI-driven data center construction, while SpaceX represents a speculative bet on long-term space economy growth.

Willis, a WTW business, announced the appointment of Lars Sorensen as Life Sciences Industry Leader for North America. Sorensen, who brings over 30 years of experience including his previous role as Life Sciences Industry Vertical Leader at Aon, will lead Willis' life sciences strategy, drive solution development, and serve as a subject matter expert. The appointment reflects Willis' continued investment in specialty talent and commitment to delivering differentiated solutions to clients in the life sciences sector.

The Invesco KBW Bank ETF (KBWB) and ProShares Ultra Financials (UYG) offer different approaches to financial sector exposure. KBWB provides straightforward banking exposure with a 0.35% expense ratio and delivered a 39.43% one-year return, while UYG uses 2x daily leverage with a higher 0.94% expense ratio and returned 14.08% over the same period. KBWB is recommended for buy-and-hold investors, while UYG is better suited for short-term traders, though leveraged ETFs carry daily reset risks and tax inefficiency concerns.

SpaceX and AST SpaceMobile are competing in the satellite communications space with different business models. SpaceX dominates rocket launches and operates Starlink with 10.3 million subscribers but faces massive capital requirements and negative free cash flow of -$14 billion in FY 2025. AST SpaceMobile is building a direct-to-device cellular network with partnerships from major carriers and expects profitability by 2027, though it currently has negative free cash flow of -$1.1 billion. The article recommends AST SpaceMobile as the better 2026 buy due to its more focused business plan and earlier path to profitability.

Malibu Boats, Inc. (MBUU) has been named a 2026 Coolest Thing Made in Tennessee finalist. The company, based in Loudon, Tennessee, is a leading designer and manufacturer of recreational powerboats across multiple brands including Malibu, Axis, Cobalt, Pursuit, and Saxdor. Public voting is open through July 29, 2026, with supporters able to cast one vote per day.

Novo Nordisk's oral Wegovy launch has regained market share in the GLP-1 weight-loss drug market, capturing ~89% of oral weight-loss medication prescriptions in the U.S. However, Eli Lilly's Foundayo has potential advantages including fewer food restrictions and upcoming label expansions for multiple indications. Both companies remain well-positioned in the fast-growing anti-obesity market with strong pipelines.

Pinterest co-founder and director Benjamin Silbermann sold 93,750 shares worth $2.1 million on July 14-15, 2026, reducing his indirect equity stake by 87% through a pre-planned Rule 10b5-1 trading arrangement. Despite maintaining over 1.2 million derivative securities, the large sale size and Pinterest's 35% stock decline over the past year amid advertising headwinds have raised investor concerns about confidence in the company.

FixGo, an online tire retailer, has expanded into San Diego County by adding 20 partner installation shops, bringing its total network to over 200 locations across Los Angeles and San Diego. The expansion allows customers to order tires online and arrange local installation with transparent, all-inclusive pricing.

The New Civil Liberties Alliance filed an amicus curiae brief with the U.S. Supreme Court in the Boysen v. PeaceHealth case, arguing that courts have misinterpreted the 1905 Jacobson v. Massachusetts decision to justify broad vaccine mandates. NCLA contends that Jacobson should only permit mandates when vaccines prevent disease transmission to third parties, and that lower courts have failed to protect individuals' liberty interests in refusing unwanted medical treatment.

Chevron has signed memorandums of understanding with Iraq to enter two major oilfields—the Nassiriya project (potential 600,000 barrels per day) and West Qurna 2 (460,000 barrels per day). The company is also evaluating pipeline routes to bypass the Strait of Hormuz, addressing export challenges caused by regional instability. These moves could significantly enhance Chevron's long-term growth prospects.

Adobe demonstrates stronger revenue momentum with eight consecutive quarters of growth, reaching $6.6 billion in Q2 2026, while Autodesk recorded its first revenue decline to $1.9 billion in Q2 2026 due to sales team reorganization. Despite leadership transitions at Adobe and market concerns about AI impact, the company maintains its competitive advantage with broader market reach compared to Autodesk's niche industry focus.

E.F. Hutton & Co. served as exclusive financial advisor and placement agent for a strategic business combination between Glucotrack, Inc. and Lōkahi Therapeutics, along with a $5.7 million convertible note financing. The transaction creates a publicly traded healthcare platform combining Lōkahi's AI-driven asset sourcing capabilities with Glucotrack's Nasdaq listing, with Lōkahi becoming the operating company and Glucotrack's CBGM business continuing as a subsidiary.

Veritone, Inc. faces a securities fraud class action lawsuit after disclosing accounting errors related to revenue recognition under ASC 606. The company restated financial statements for Q3 2025, revealing overstated revenue and understated net losses due to misclassification of barter transactions and software valuation errors. The stock declined significantly following multiple disclosure announcements in March and April 2026. Investors have until July 20, 2026 to file a lead plaintiff motion.

Clariant received a EUR 1.1 billion damages claim from Dow Europe on July 16, 2026, related to alleged competition law infringement on the ethylene purchasing market sanctioned by the European Commission in July 2020. Clariant firmly rejects the allegations and states it has economic evidence that the conduct had no market effect.

Banco Comercial Português, S.A. has released an interim report on its Share Buy-Back Programme transactions. Additionally, the bank has announced estimated provisions against legal risk related to its FX mortgage loans portfolio held by subsidiary Bank Millennium, S.A. in Q2 2026.

Joby Aviation's stock has declined 47% year-to-date, but the article argues this presents a buying opportunity for long-term investors. Despite slow regulatory progress, Joby has made significant operational advances including thousands of test miles, strategic partnerships with Toyota, Delta, and Uber, and participation in a White House-backed eVTOL program. The author views the stock as a speculative long-term play with potential for substantial gains if the urban air mobility market reaches projected valuations.

Sandisk stock has surged over 3,000% in the past 12 months, trading around $1,400 per share as of July 2026. While a stock split may seem likely, management may hold off due to strong investor demand, potential short-term trader influx, and the availability of fractional investing. The company's growth is driven by AI infrastructure demand, with data center revenue up 645% and edge business revenue up 295% in Q3 fiscal 2026. Long-term success depends on maintaining consistent revenues through multiyear contracts rather than expecting continued 3,000% annual gains.

Nvidia stock dropped nearly 5% on Friday following news that Chinese startup Moonshot AI unveiled a new model that narrows the gap with top U.S. AI systems. The decline reflects investor concerns about lower-cost AI alternatives reducing capital spending on infrastructure. However, the article argues the reaction is overdone, noting Nvidia continues strong growth and recently announced expansion in Japan.

Hagens Berman has expanded a securities class action lawsuit against Roblox Corporation, covering investors who purchased stock between October 31, 2024 and April 30, 2026. The litigation focuses on alleged misleading disclosures regarding user safety and the impact of age-check verification rollout, which resulted in a 16% stock decline and significant revenue guidance cuts.

Soitec reports on its liquidity contract managed by BNP Paribas for the first half of 2026. During H1 2026, 227,346 shares were purchased for €17.36 million and 288,875 shares were sold for €23.29 million across 4,546 transactions. The liquidity account held 24,442 shares and €6.36 million as of June 30, 2026.

Hub Group (HUBG) faces a securities class action lawsuit alleging material financial misstatements, improper revenue recognition, and internal control deficiencies spanning 2023-2026. The company revealed accounting errors totaling $77 million in 2025 and restated prior year financials, resulting in $890 million in market capitalization loss and executive departures.

Following a chip stock sell-off on July 13 due to geopolitical tensions, the article recommends two semiconductor stocks for long-term investors: Nvidia, trading at attractive valuations relative to its GPU market dominance and AI infrastructure growth potential, and Marvell Technology, a leading ASIC maker positioned to benefit from increasing demand for custom AI chips from hyperscalers like Amazon and Alphabet.

Hagens Berman is investigating a securities class action against Veritone, Inc. (VERI) following the company's admission of materially misstated financial statements. The company improperly recorded revenue, overstated assets and accounts receivable, and maintained deficient internal controls during October 2025 to April 2026. Multiple disclosures in early 2026 caused significant stock declines, with the final disclosure on April 14, 2026 revealing errors in software valuation and revenue misclassification. Investors who suffered losses during the class period are eligible to serve as lead plaintiff with a July 20, 2026 deadline.

Hagens Berman is investigating GRAIL, Inc. for allegedly misleading investors about its NHS-Galleri cancer screening trial. The company failed to disclose that a three-year follow-up period was insufficient to meet the trial's primary endpoint. When GRAIL revealed the trial failure on February 19, 2026, its stock collapsed 50.55%, erasing $2.2 billion in market capitalization. The class action covers the period from May 13, 2025 to February 19, 2026, with a lead plaintiff deadline of August 4, 2026.

Three industry leaders—Unipart, KBR, and IBM—have announced Team ORION, a joint venture to provide operational resilience, logistics, and technology solutions to the UK Ministry of Defence. The partnership combines Unipart's supply chain expertise, KBR's defence experience, and IBM's digital capabilities to create a sovereign, integrated defence support capability.

Three companies announced significant developments in advanced materials and infrastructure: Xeriant secured a U.S. patent for its fire-resistant composite technology (NEXBOARD), Argo Graphene Solutions appointed graphene scientist Dr. Vikas Berry as CEO to accelerate commercialization of its STREAM platform, and Aecon Group and Southland Holdings won a C$815 million wastewater treatment contract in Winnipeg, expanding their infrastructure backlogs.

Compass Therapeutics announced that its abstract for tovecimig, a DLL4 x VEGF-A bispecific antibody, has been accepted for an oral presentation at the ESMO Congress 2026 in Madrid. The presentation will showcase Phase 2/3 COMPANION-002 trial results evaluating tovecimig combined with paclitaxel in patients with advanced biliary tract cancer, to be presented by Dr. Nilofer Azad from Johns Hopkins University on October 24, 2026.

Warren Buffett revealed he personally initiated Berkshire Hathaway's significant investment in Alphabet, adding over $20 billion to the position in 2025. Buffett expressed regret for not buying earlier and highlighted Alphabet's strong returns on capital and diverse business portfolio as reasons for the investment, signaling cautious optimism toward AI despite concerns about massive capital expenditures required for AI infrastructure.

AST SpaceMobile's stock plummeted 25% this week after the company announced a $1 billion convertible bond offering, surprising investors given its $3 billion cash balance. The company faces significant headwinds including $1.37 billion in annual cash burn, operational delays from Blue Origin launch failures, and a high conversion price of $79.60 versus the current $55 share price. Despite the decline, the stock remains expensive relative to fundamentals.

Independent author Noelle Hipke's second book in the Ascension Series, 'Earth Games: Playbook Rules & Regulations,' won Silver in the 2026 COVR Visionary Awards. Her debut book 'Superpowers' achieved Amazon #1 bestseller status and multiple national literary awards. Hipke is completing the trilogy while seeking literary representation and publishing partnerships.

The global Military Drone (UAV) Market is projected to grow from USD 34.85 billion in 2026 to USD 109.22 billion by 2031 at a CAGR of 25.7%, driven by rising defense budgets, geopolitical tensions, and advancements in AI and autonomy. Strategic drones and ISR applications dominate the market, with North America leading and the Middle East & Africa showing fastest growth. Key players include Northrop Grumman, RTX, and General Atomics.

The global financial analytics market is projected to grow from $12.15 billion in 2025 to $36.10 billion by 2035, driven by AI adoption, cloud computing, and predictive analytics. North America leads with 35% market share, while Europe and Asia Pacific show strong growth potential. Large enterprises dominate, but SMEs are expected to grow fastest due to affordable cloud-based solutions.

The global muscle stimulator market is valued at $812.01 million in 2025 and is projected to reach $1,156.54 million by 2035, growing at a CAGR of 3.6%. Growth is driven by increasing adoption of neuromuscular electrical stimulation devices for pain management, rehabilitation, and sports medicine. TENS technology dominates with 67.4% market share, while portable devices account for 46.88% of the market. North America leads with 41.9% revenue share, while Asia Pacific registers the fastest growth.

The global livestock monitoring market is projected to grow from $6.2 billion in 2025 to $10.3 billion by 2030 at a 10.6% CAGR, driven by AI-enabled precision farming, IoT sensors, and wearable technologies. Europe leads with 33.2% market share, while regulatory compliance and rising protein demand are key growth catalysts.

Atlas Healthcare Fund, managed by VST Capital, showcased its track record of early conviction investments in healthcare, with notable positions in Eli Lilly (entered at $350, now trading above $1,200), Alnylam Pharmaceuticals, TransMedics Group, and Inari Medical. The fund has delivered cumulative net returns of +1,720.9% since inception in January 2020, averaging over 57% annually, by identifying clinically differentiated technologies before mainstream market recognition.

American Critical Minerals Corp. announced that its President and CEO Dean Pekeski will present at the Precious Metals & Critical Minerals Virtual Investor Conference on July 23rd, 2026. The company is advancing exploration of its Green River Project in Utah's Paradox Basin, with plans to commence drilling operations in August 2026 targeting potash, lithium, and bromine deposits.

Revolution Medicines, a pre-revenue biotech company developing targeted cancer treatments to replace chemotherapy, has surged 125% in 2026. The company's flagship drug Daraxonrasib received FDA Breakthrough Therapy designation and is undergoing accelerated review by the EMA. Billionaire Stanley Druckenmiller's Duquesne Family Office purchased 316,000 shares worth $30.6 million in Q1 2026, now valued at $56.6 million, signaling confidence in the company's potential despite its speculative nature.

Rising AI adoption is driving massive energy demand from data centers, positioning nuclear energy—particularly small modular reactors (SMRs)—as an ideal solution. NuScale Power and Oklo are two early-stage SMR companies positioned to benefit from this trend, though both face regulatory hurdles and commercialization risks. Major investment banks including Goldman Sachs, Bank of America, and Morgan Stanley are bullish on nuclear's renaissance.

Amneal Pharmaceuticals received FDA approval for additional strengths and vial presentations of iohexol injection (350 mg iodine/mL and 300 mg iodine/mL), with planned Q3 2026 launch. The expanded portfolio is expected to address the majority of U.S. iohexol injection market demand, which generated approximately $706 million in annual sales as of May 2026.

VisionWave Holdings announced the filing of a provisional patent application for GhostSight™, a hybrid passive radar system designed for defense and security applications. The system combines existing environmental RF signals with cooperative illumination sources to detect and track objects while maintaining a receive-only passive receiver layer. The technology is intended for military base protection, counter-UAS operations, border surveillance, and critical infrastructure protection.

Jackery announced that its FridgeGuard, an ultra-slim refrigerator backup battery system, is now available exclusively at Costco. The device offers 15 hours of runtime, instant 10ms UPS switchover, and 1600W output to protect refrigerators during power outages. Priced at $549.99 for Costco members, FridgeGuard requires no installation and features a compact 2.6-inch profile, addressing the growing concern of power outages affecting U.S. households.

The article compares two Vanguard ETFs—VOO (S&P 500) and VTI (Total Stock Market)—as potential bear market hedges. While both track broad U.S. stock markets with similar top holdings, VTI offers slightly better diversification with lower tech concentration (35% vs 40%), making it potentially less vulnerable to AI sector volatility. However, VOO has outperformed recently due to tech strength.

The Trade Desk's stock has plummeted 76% in 2026 due to slowing growth expectations, intense competition from Amazon's DSP, a public dispute with Publicis, management turnover, and macro headwinds. While trading at historically cheap valuations (6x adjusted EBITDA), the company faces significant near-term and long-term challenges that must be resolved before it becomes an attractive investment opportunity.

Goodfirms has released a comprehensive vendor guide for building prediction marketplace platforms, featuring 100+ vetted providers across 20 technology categories and 4 build phases, with costs ranging from $25,000 to $2,000,000+. The resource maps vendors through Foundation, Compliance & Risk, Product Build, and Launch & Operations phases, treating platform development as a procurement problem rather than purely an engineering challenge.

BrewDog and Tilray Brands are launching a £1 million bar tab promotion at participating BrewDog pubs across England, Scotland, and Ireland from July 20 through September 30, 2026. The promotion offers fans two free pints per person via the BrewDog Treats loyalty platform, available on a first-come, first-served basis. The initiative aims to bring football supporters together for watch parties and celebrations throughout the tournament season.

Kalaris Therapeutics announced positive Phase 1a data for TH103, its investigational treatment for neovascular AMD. The expanded trial of 17 treatment-naive patients showed improvements in vision and retinal anatomy, with 29% requiring no additional anti-VEGF treatment during six-month follow-up. TH103 demonstrated 27-53 fold lower plasma levels compared to leading anti-VEGF agents while maintaining efficacy. The company is actively enrolling patients in Phase 1b/2 trials with preliminary data expected in H1 2027.

The global mass spectrometry market is valued at $6.68 billion in 2025 and is projected to reach $14.09 billion by 2035, growing at a CAGR of 7.74%. Growth is driven by pharmaceutical manufacturing, omics research, clinical diagnostics, and precision medicine adoption. North America leads the market while Asia Pacific records the fastest growth at 9.12% CAGR.

ResearchAndMarkets.com released a comprehensive report analyzing over 1,859 clinical-stage pharmaceutical and biotechnology partnership deals announced since 2020. The report provides detailed financial terms, deal structures, contract documents, and insights into negotiation dynamics for clinical-stage drug development collaborations, serving as a benchmarking resource for biopharma dealmakers.